Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,279
Closed -$1.68M 387
2024
Q4
$1.68M Sell
23,279
-1,325,588
-98% -$104M 0.01% 288
2024
Q3
$110M Buy
1,348,867
+145,297
+12% +$11.6M 0.75% 62
2024
Q2
$89.4M Sell
1,203,570
-44,376
-4% -$3.33M 0.64% 72
2024
Q1
$97.3M Buy
1,247,946
+86,935
+7% +$6.47M 0.69% 68
2023
Q4
$83M Sell
1,161,011
-21,254
-2% -$1.48M 0.65% 71
2023
Q3
$82M Sell
1,182,265
-9,253
-0.8% -$699K 0.73% 70
2023
Q2
$96.5M Buy
+1,191,518
New +$97.4M 0.84% 58

Other funds holding HOLX

Congress Asset Management's HOLX Position: Q1 2025 in Review

Congress Asset Management sold out of Hologic (HOLX) in Q1 2025, closing a stake of 23,279 shares — an estimated $1.68M sold.

Congress Asset Management first reported a position in HOLX in Q2 2023 and held it in 7 quarters. The position peaked at $110M in Q3 2024. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Congress Asset Management reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Congress Asset Management sold 23,279 Hologic shares in Q1 2025, an estimated $1.68M.
  • Congress Asset Management first reported a position in Hologic in Q2 2023 and held it in 7 quarters.
  • Congress Asset Management's Hologic position peaked at $110M in Q3 2024.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Congress Asset Management's 13F filing for Q1 2025, filed 11 Apr 2025.